Embracing Future Holdings Limited (SGX:8YY)

Singapore · Delayed Price · Currency is SGD

0.0400

+0.0060 (17.65%)

At close: Sep 11, 2026

Market Cap	69.34M +73.9%
Revenue (ttm)	6.82M +173.6%
Net Income	-3.05M
EPS	-0.00
Shares Out	1.73B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,265,500
Open	0.0330
Previous Close	0.0340
Day's Range	0.0330 - 0.0400
52-Week Range	0.0210 - 0.0920
Beta	0.63
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2026

About Embracing Future Holdings

Embracing Future Holdings Limited, a precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions in Singapore, China, and Hong Kong. It operates through Cancer, Infectious Diseases, E-Sports, and Advertising segments. The company offers ClearCell FX1 System that includes Streck Cell-free DNA BCT and EDTA tubes, a fully automated device for cell retrieval that can separate wholly intact and viable circulating tumour cells, or CTCs from small amounts of blood; and CTChip FR1 biochip that isolate the CT... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus

Founded 2009

Employees 16

Stock Exchange Singapore Exchange - Catalist

Ticker Symbol 8YY

Full Company Profile

Financial Performance

In 2025, Embracing Future Holdings's revenue was 5.26 million, an increase of 513.17% compared to the previous year's 858,000. Losses were -3.96 million, 15.4% more than in 2024.

Financial Statements